NeuroMetrix Inc (NAS:NURO)
$ 4.27 -0.03 (-0.7%) Market Cap: 8.72 Mil Enterprise Value: -5.97 Mil PE Ratio: 0 PB Ratio: 0.54 GF Score: 60/100

NeuroMetrix Inc at Emerging Growth Conference (Virtual) Transcript

Nov 01, 2023 / 07:40PM GMT
Release Date Price: $3.61 (-3.01%)
Ana Berry
EmergingGrowth.com - Moderator

Welcome back, everyone. We have an update from NeuroMetrix, Inc., which trades on the Nasdaq under the symbol, NURO. It is a commercial stage healthcare company that develops and commercializes neuro technology devices to address unmet needs in the chronic pain and diabetes market.

Happy to welcome Dr. Shai Gozani, CEO, for this update. Welcome, Dr.

Shai Gozani
NeuroMetrix, Inc. - President, CEO & Chairman of the Board

Thank you, Ana, and thank you for joining us today. So I'll start with the traditional forward-looking statement disclaimer. Please take a look at our recently filed Q and K for a complete listing of risk factors.

So just by way of reminder before I kind of focus in on our core fibromyalgia business, I wanted to remind everyone that at NeuroMetrix, our mission is to improve the lives of patients with complex chronic pain conditions through neuromodulation devices.

And just in terms of our investor thesis, we think it's pretty straightforward. We've had a significant

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot